SpectraScience, Inc.
SCIE · OTC
12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.00 | -0.01 | 0.01 |
| FCF Yield | -127.54% | -671.96% | -102.27% | -57.41% |
| EV / EBITDA | -2.59 | -2.18 | -2.21 | -2.22 |
| Quality | ||||
| ROIC | 80.65% | 242.06% | 750.69% | 1,275.92% |
| Gross Margin | -3,766.99% | 90.88% | 50.00% | 47.75% |
| Cash Conversion Ratio | 0.34 | 0.52 | 0.54 | 0.59 |
| Growth | ||||
| Revenue 3-Year CAGR | -31.70% | -69.82% | -67.28% | 107.83% |
| Free Cash Flow Growth | 19.95% | 22.81% | -51.41% | 44.08% |
| Safety | ||||
| Net Debt / EBITDA | -2.24 | -2.08 | -1.35 | -0.95 |
| Interest Coverage | -2.12 | -2.43 | -5.41 | -1.19 |
| Efficiency | ||||
| Inventory Turnover | 2.20 | 0.01 | 0.03 | 0.51 |
| Cash Conversion Cycle | -2,180.72 | -502,375.18 | -24,949.51 | -2,125.57 |